Financial Health Assessment: CKMV LTD

1. Financial Health Score: F

Explanation: The company is in critical condition, displaying severe signs of financial distress. It is technically insolvent, with total liabilities exceeding total assets by over £400,000. The business is surviving entirely on life support via director loans, has negligible revenue-generating assets, and is bleeding cash through compounding debt obligations. Without significant intervention, the company's viability is extremely compromised.

2. Key Vital Signs

• Liquidity (Blood Pressure): Critical Low. The company’s current assets amount to a mere £376, against current liabilities of £273,233. This yields a current ratio of roughly 0.001, meaning the business has virtually no liquid resources to cover its short-term debts. The cash position is technically in overdraft (£-4), indicating complete cash flow exhaustion.
• Solvency (Body Mass Index): Severely Underweight. Net assets stand at a negative £406,402. The business is financially underwater; if all assets were liquidated today, there would still be over £400k owed to creditors. This is a stark deterioration from a healthy positive position in 2019/2020.
• Profitability (Metabolism): Hemorrhaging. The accumulated losses in the Profit & Loss account have grown from £-368,200 in 2024 to £-406,403 in 2025. The company is consistently spending more than it earns, with no sign of the bleeding stopping.
• Debt Structure (Cholesterol): Highly Toxic. The liability structure is dominated by £109,582 in director loans and £145,125 in accrued preference dividends. Furthermore, the company carries £100,000 in non-equity preference shares with a crippling 15% annual dividend, which is compounding unpaid.

3. Diagnosis

CKMV LTD is suffering from chronic insolvency and operational failure. The financial data reveals a business that has been unprofitable for several consecutive years, steadily consuming its own equity since 2020.

The most concerning symptom is the £100,000 preference share issue with a 15% dividend rate. This structure acts like a financial parasite—compounding unpaid dividends at £15,000 annually, which the business simply cannot afford. This accrued dividend now accounts for over half of the company's short-term liabilities.

The company has zero employees and minimal tangible assets (computer equipment is fully depreciated), suggesting operations have essentially ceased, yet the administrative and financial costs continue to accumulate. The business is only kept alive on the ventilator of director loans and the director's stated intention to continue providing funding, as noted in the going concern statement. While this life support prevents immediate administration, it does not cure the underlying disease.

4. Recommendations

To stabilize the patient, drastic and immediate interventions are required:

1. Stop the Bleeding (Dividend Restructuring): The 15% preference share dividend is unsustainable. You must negotiate with the preference shareholders to either freeze the dividend accrual, drastically reduce the rate, or convert these shares and their accrued interest into ordinary equity to clear the current liability blockage.
2. Assess Viability (Palliative Care vs. Recovery): With zero employees and no revenue-generating assets, the core business appears dormant. The director must honestly assess whether there is a realistic, profitable business model that can be executed. If not, continuing to trade and accumulate debt risks crossing into wrongful trading.
3. Seek Specialist Referral (Insolvency Practitioner): Given the negative net assets exceeding £400k, the director should urgently consult with a licensed insolvency practitioner. They can advise on whether a formal restructuring tool (like a Company Voluntary Arrangement) is possible, or if the most responsible course of treatment is to place the company into voluntary liquidation to bring closure to the compounding liabilities.
4. Capital Injection (Transfusion): If the director believes the business can be resurrected, the outstanding director loan (£109k) should be formally capitalized (converted into equity). This won't fix the cash flow, but it will clean up the balance sheet and reduce the pressure of an immediate call on those funds.